Polycythemia vera megakaryocytes but not megakaryocytes from normal controls and patients with smokers polyglobuly spontaneously express IL-6 and IL-6R and secrete IL-6

Leukemia

Volumn 13, Issue 3, 1999, Pages 327-334

  Wickenhauser, C ^a   Thiele, J ^a   Lorenzen, J ^a   Schmitz, B ^a   Frimpong, S ^a   Schramm, K ^a   Neumann, I ^a   Zankovich, R ^a   Fischer, R ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

IL 6; Megakaryocytes; Polycythemia rubra vera; Reverse hemolytic plaque assay

Indexed keywords

INTERLEUKIN 3; INTERLEUKIN 6; MESSENGER RNA;

ADULT; ARTICLE; BLOOD DONOR; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MEGAKARYOCYTE; POLYCYTHEMIA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; VIRUS CULTURE;

EID: 0033014569     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401314     Document Type: Article

References (40)

1. Bilgrami S, Greenberg BR. Polycythemia rubra vera. Semin Oncol 1995; 22: 307-326.
2. Dai CH, Krantz SB, Dessypris EN, Means RT, Horn ST, Gilbert HS. Polycythemia vera II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin 3 and granulocyte-macrophage colony stimulating lactor. Blood 1992; 80: 891-899.
3. Le Bousse-Kerdiléres MC, Souyri M, Smadja-Joffee F, Praloran V, Jasmin C, Ziltener HJ. Enhanced hematopoietic growth factor production in an experimental myeloproliferative syndrome. Blood 1992; 79: 3179-3185.
4. Everson MP, Brown CB, Billy MB. Interleukin 6 and granulocyte-macrophage colony stimulating factor (Meg-CSF) is a unique cytokine specific for the megakaryocyte lineage. Br J Haematol 1989; 74: 1472-1478
5. Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M. Interleukin 6 enhancement of interleukin 3 dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 1987; 84: 9035-9039.
6. Suematsu S, Matsuda T, Aozasa K, Akira S, Nakano N, Ohno S, Miyazaki J-I, Yamamura K-I, Hirano T, Kishimoto T. IgGI plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 1989; 86: 7547-7551.
7. Gastl G, Plante M, Finstad CL, Wong GY, Frederici MH, Bander NH, Rubin SC. High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br J Haematol 1993; 83: 433-439.
8. Straneva JE, van Besien KW, Derigs G, Hoffman R. Is interleukin 6 the physiological regulator of thrombopoiesis? Exp Hematol 1992; 20: 47-50.
9. Tefferi A, Ho TC, Ahmann GJ, Katzmann JA, Greipp PR. Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis. Am J Med 1994; 97: 374-380.
10. Hawley RG. Interleukin 6 type cytokines in myeloproliferative disease. Ann NY Acad Sci 1995; 762 294-307.
11. Metcalf D. The roles of stem cell self-renewal and autocrine growth factor production in the biology of myeloid leukemia. Cancer Res 1989; 49: 2305-2311.
12. Lotem J, Sachs L. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 1992; 80: 1750-1756.
13. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin 6. Nature 1991; 352: 345-347.
14. Wickenhauser C, Lorenzen J, Thiele J, Hillienhof A, Jungheim K, Schmitz B, Hansmann M-L, Fischer R. Secretion of cytokines (IL-1α, IL-3, and IL-6 and GM-CSF) by normal human bone marrow megakaryocytes. Blood 1995; 85: 685-691.
15. Schaefer HE. How to fix, decalcify and stain paraffin embedded bone marrow biopsies. In: Lennert K, Huebner K (eds). Pathology of the Bone Marrow. G Fischer: Stuttgart, New York, 1984, pp 6-9.
16. Schmitz B, Radbruch A, Wickenhauser C, Kümmel T, Korb H, Hansmann M-L, Thiele J, Fischer R. Magnetic activated cell sorting (MACS) - a new immunomagnetic method for megakaryocyte cell isolation. Comparison of different separation techniques. Eur J Haematol 1994; 52: 267-270.
17. Butch AW, Chung G-H, Hoffmann JW, Nahm MH. Cytokine expression by germinal center cells. J Immunol 1993; 150: 39-44.
18. D'Aquila RT, Bechtel LJ, Videler JA, Eron JJ, Gorczycz P, Kaplan JC. Maximizing sensitivity and specificity of PCR by preamplification heating. Nucleic Acids Res 1991; 19: 3749-3753.
19. Tomer A, Harker LA, Burstein SA. Purification of human megakaryocytes by fluorescence-acticated cell sorting. Blood 1987; 70: 1735-1742.
20. Rohde D, Wickenhauser C, Denecke S, Stach A, Lorenzen J, Hansmann M-L, Thiele J, Fischer R. Cytokine release by human bone marrow cells: analysis at the single cell level. Virchows Arch 1994; 424: 389-395.
21. Wickenhauser C, Hillienhof A, Jungheim K, Lorenzen J, Ruskowski H, Hansmann M-L, Thiele J, Fischer R. Detection and quantification of TGFβ and PDGF release by normal human megakaryocytes. Leukemia 1995; 9: 310-315.
22. Gatter KC, Cordell JL, Turley H, Heryet A, Kieffer N, Anstee DJ, Mason DY. The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens. Histopathol 1988; 13: 257-267.
23. Bayer AB, Wilchek M. The use of the avidin-biotin complex as a tool in molecular biology. Meth Biochem Anal 1990; 26: 1-45.
24. Rotman B, Papermaster BM. Membrane properties on living mammalian cells as studied by enzymatic hydrosis of fluorogenic esters. Proc Natl Acad Sci USA 1966; 55: 134-138
25. Debili N, Issaad C, Masse J-M, Guichard J, Katz A, Breton-Gorius J, Vainchenker W. Expression of CD34 and platelet glycoproteins during megakaryocytic differentiation. Blood 1992; 80: 3022-3035.
26. Phillips DR, Charo IF, Scarborough RM. GPIIb-IIIa: the responsive integrin. Cell 1991; 65: 359-362.
27. Michiels JJ, Juvonen E. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group. Semin Thromb Hemostas 1997; 23: 339-347.
28. Prchal JT, Prchal JF. Evolving understanding of the cellular defect in polycythemia vera: implications for its clinical diagnosis and molecular pathophysiology. Blood 1994; 83: 1-4.
29. Williams N, Levine RF. The origin, development and regulation of megakaryocytes. Br J Haematol 1982; 52: 173-180.
30. Hoffman R. Regulation of megakaryopoiesis. Blood 1989; 74: 1196-1212.
31. Ishibashi T, Kimura H, Uchida T, Kariyone S, Friese P, Burstein SA. Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 1989; 86: 5953-5957.
32. Schirmacher P, Peters M, Ciliberto G, Blessing M, Lotz J, Meyer zum Büschenfelde KH, Rose John S. Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/ soluble IL-6 receptor double - transgenic mice. Am J Pathol 1998; 153: 639-648.
33. Navarro S, Debili N, Le Couedic J-P, Klein B, Breton-Gorius J, Doly J, Vainchenker W. Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication. Blood 1991; 77: 461-471.
34. Schmitz B, Thiele J, Witte O, Kaufmann R, Wickenhauser C, Fischer R. Influence of cytokines (IL-1a, IL-3, IL-11, GM-CSF) on megakaryocyte-fibroblast interactions in normal human bone marrow. Eur J Hematol 1995; 55: 24-32.
35. Sato T, Fuse A, Eguchi M, Hayashi Y, Sugita K, Nakazawa S, Minato K, Shima Y, Komori I, Sunami S, Okimoto Y, Nakajimi H. Establishment and characterisation of a megakaryoblastic cell line CMK from a Down's syndrome patient with acute megakaryoblastic leukaemia. Br J Haematol 1989; 72: 184-190.
36. Kobayashi S, Teramura M, Hoshino S, Motoji T, Oshimi K, Mizoguchi H. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin 3. Br J Haematol 1993; 83: 539-544.
37. Zauli G, Catani L, Gugliotta L, Gaggioli L, Vitale L, Mattioli Belmonte M, Aglietta M, Bagnara GP. Essential throbocythemia: impaired regulation of megakaryocyte progenitors. Int J Cell Cloning 1991; 9: 43-51.
38. Levine RF, Hazzard KC, Lamberg JD. The significance of megakaryocyte size. Blood 1982; 60: 1122-1131.
39. Thiele J, Fischer R. Megakaryopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. Virchows Arch A Pathol Anat 1991; 418: 87-93.
40. Thiele J, Zankovich R, Schneider G, Kremer B, Fischer R, Diehl V. Primary (essential) thrombocythemia versus polycythemia vera rubra. Anal Quant Cytol Histol 1988; 10: 375-381.